Stock & Company Details
Altimmune Inc $ALT
Price:
N/A
N/A
195M
$506M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.81
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
ALT technical indicators
Latest Altimmune Inc (ALT) indicator readings as of 2026-10-09.
ALT's 14-day RSI is 28.0, in oversold territory. At $2.61 it is trading 23.5% below its 200-day moving average of $3.41, and below its 50-day average of $3.06. Price sits near the lower Bollinger Band ($2.46 to $3.51). ADX reads 27.9, indicating a trending market.
Overview
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
Finance Bot
Ask your questions
Start by typing a question below.
